Navigation Links
B. Braun Obtains Permanent Injunction
Date:5/4/2011

BETHLEHEM, Pa., May 4, 2011 /PRNewswire/ -- Germany-based medical device manufacturer B. Braun Melsungen AG and its U.S. subsidiary B. Braun Medical Inc. (B. Braun) announced today that the company succeeded in obtaining a permanent injunction in its patent infringement case against Japan's Terumo Corporation and its U.S. subsidiary Terumo Medical Corporation.

(Logo:  http://photos.prnewswire.com/prnh/20081022/NYW008LOGO)

On April 21, 2011, the U.S. District Court for the District of Delaware granted an immediate and permanent order, stopping Japan's Terumo Corporation and its U.S. subsidiary Terumo Medical Corporation from selling, or offering to sell, the Surshield® Safety IV Catheter in the acute care market, and precluding Terumo from bidding against B. Braun on expiring GPO contracts. Terumo will be permitted to continue selling the Surshield Safety IV Catheter into the alternative care market until June 1, 2012 after which it cannot make, sell, use or offer the Surshield Safety Catheter in the U.S.  B. Braun will seek damages and other relief for Terumo's infringement.

B. Braun's win follows a previous verdict awarded in November 2010, confirming the validity of an infringed claim of B. Braun's 2007 patent (U.S. Patent 7,264,613) for its Introcan Safety® IV Catheter.

About B. Braun's Introcan Safety® IV Catheter

B. Braun's Introcan Safety® IV Catheter, a passive, fully automatic safety device, designed to help protect against accidental needlestick injuries (NSIs). NSIs and other sharps injuries expose hundreds of thousands of healthcare providers each year to serious blood borne pathogens like hepatitis C and HIV. With the Introcan Safety® IV Catheter, the safety device is activated automatically and cannot be bypassed.

A recent landmark study conducted by GERES (Groupe d'Etude sur le Risque d'Exposition des Soignants) of 22 million safety devices used in 61 French hospitals over a two-year period has confirmed the theory that passive, fully automatic safety devices like B. Braun's Introcan Safety® IV Catheter offer significantly better protection against NSIs than early generation active safety technologies such as semi-automatic (push-button) devices or those with manually sliding shields or hinged caps.

For more information about B. Braun's Introcan Safety® IV Catheter visit http://introcansafety.bbraunusa.com.  

About B. Braun

B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company's "Sharing Expertise®" philosophy,

B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.

Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, email us at inquiry.us@bbraun.com or visit B. Braun at www.bbraunusa.com.


'/>"/>
SOURCE B. Braun
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. B. Braun Offers Wound Patients a New Over-the-Counter Wound Management Gel - Prontosan®
2. B. Braun Voluntarily Recalls Seven Lots of Heparin Manufactured in 2008 Due to Supplier-Initiated Recall of Heparin Active Pharmaceutical Ingredient (API)
3. B. Braun Wins Third Consecutive Safety IV Catheters Contract Award from Premier, Inc.
4. FDA-Approved Cefepime Now Available for Use in B. Brauns DUPLEX® System
5. B. Braun Customers Gain Premier Access to Zynx Health Device Networks Evidence-based, Customizable Drug Library Program
6. B. Braun Large Volume Heparin Infusion Solutions Now Available
7. New Technology Center Increases B. Brauns Infusion Pump Capacity
8. Health Robotics Re-Acquires CytoCares European Rights from B. Braun Melsungen AG for Undisclosed Consideration
9. FDA Approves Cefepime for Use In B. Brauns DUPLEX(R) System
10. B. Braun Renal Therapies Division Announces Availability of Adimea
11. B. Braun Infusion Systems Complete Interoperability Test for HIMSS10 Interoperability Showcase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... - bioLytical lanza el INSTI HIV Self Test ... Continue Reading ... New: ... , , bioLytical Laboratories (la "Compañía"), ... está expandiendo el lanzamiento de su INSTI HIV Self Test  a África con ...
(Date:12/2/2016)... North America held the largest share in the ... aged population and demand for remote monitoring ECG devices. On ... region is expected to witness the highest growth rate during ... Company (U.S.), Becton, Dickinson and Company (U.S.), Medtronic plc ( ... Netherlands ) and Mindray Medical International Limited ( ...
(Date:12/2/2016)... Research and Markets has announced the addition of the ... 2022" report to their offering. ... , The global ultrasound device ... expected to grow at a CAGR of 5.5% during 2016-2022. Based on ... the forecast period, a CAGR of 8.8% in the global market. Among ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... The PAINWeekEnd ... Beach Resort and Spa in Honolulu, offering local frontline clinicians the opportunity to ... , The demand for supplemental training related to pain management has surged ...
(Date:12/2/2016)... ... ... Yisrayl Hawkins, at The House of Yahweh in Abilene, Texas, has published ... Yisrayl says this generation, known as the Last Generation, started in 1934 A.Y. (After ... up exactly with Bible Prophecy – a protected way for those who will believe. ...
(Date:12/2/2016)... ... December 02, 2016 , ... Today CloudMine, a ... applications, was named the best Sales Team of 2016 as part of the ... today by the Software & Information Industry Association (SIIA), the principal trade association ...
(Date:11/30/2016)... (PRWEB) , ... November 30, 2016 , ... ... that they now offer a comprehensive in-house dental plan for all patients. Understanding ... developed a plan that gives patients a number of perks, including discounts on ...
(Date:11/30/2016)... ... November 30, 2016 , ... Center ... has announced the opening of a new residential mental health treatment program in ... health issues such as severe anxiety, depression, bi-polar disorder, and other related issues. ...
Breaking Medicine News(10 mins):